CIPROFLOXACIN (INTRAVENOUS ORAL) VERSUS CEFTAZIDIME IN LOWER RESPIRATORY-TRACT INFECTIONS

被引:18
作者
HADDOW, A
GREENE, S
HEINZ, G
WANTUCK, D
机构
[1] ST JOHNS REG HLTH CTR,DEPT MED,SPRINGFIELD,MO
[2] ST JOHNS REG HLTH CTR,DEPT PHARM,SPRINGFIELD,MO
关键词
D O I
10.1016/0002-9343(89)90036-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S113 / S115
页数:3
相关论文
共 9 条
[1]  
BERGAN T, 1987, AM J MED, V82, P97
[2]  
FASS RJ, 1987, AM J MED, V82, P202
[3]   MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF CIPROFLOXACIN IN NORMAL VOLUNTEERS [J].
GONZALEZ, MA ;
URIBE, F ;
MOISEN, SD ;
FUSTER, AP ;
SELEN, A ;
WELLING, PG ;
PAINTER, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :741-744
[4]   PROSPECTIVE RANDOMIZED CONTROLLED-STUDY OF CIPROFLOXACIN VERSUS IMIPENEM-CILASTATIN IN SEVERE CLINICAL INFECTIONS [J].
LODE, H ;
WILEY, R ;
HOFFKEN, G ;
WAGNER, J ;
BORNER, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) :1491-1496
[5]   TREATMENT OF RESPIRATORY-TRACT INFECTIONS WITH CIPROFLOXACIN [J].
RAOOF, S ;
WOLLSCHLAGER, C ;
KHAN, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :139-145
[6]  
SANDERS CC, 1987, AM J MED, V82, P2
[7]   THE FLUOROQUINOLONES - STRUCTURES, MECHANISMS OF ACTION AND RESISTANCE, AND SPECTRA OF ACTIVITY INVITRO [J].
WOLFSON, JS ;
HOOPER, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (04) :581-586
[8]  
1988, NATIONAL COMMITTEE C
[9]  
1984, NATIONAL COMMITTEE C